Long-term intense FDG uptake in a non-infected prosthetic aortic heart valve implanted 18 years ago
J Nucl Cardiol
.
2023 Feb;30(1):408-410.
doi: 10.1007/s12350-021-02764-x.
Epub 2021 Aug 19.
Authors
Albert Roque
1
2
,
Emilia Blanco
3
,
Santiago Aguadé-Bruix
4
5
,
Núria Fernández-Hidalgo
4
6
,
Hug Cuellar-Calabria
7
4
,
María Nazarena Pizzi
4
8
Affiliations
1
Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain. albert_roque@hotmail.com.
2
Universitat Autònoma de Barcelona, Departament de Medicina, Barcelona, Spain. albert_roque@hotmail.com.
3
Department of Cardiology, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
4
Universitat Autònoma de Barcelona, Departament de Medicina, Barcelona, Spain.
5
Department of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
6
Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
7
Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
8
Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
PMID:
34414551
DOI:
10.1007/s12350-021-02764-x
No abstract available
MeSH terms
Aortic Valve / surgery
Fluorodeoxyglucose F18
Heart Valve Prosthesis Implantation*
Heart Valve Prosthesis*
Heart Valves / surgery
Humans
Substances
Fluorodeoxyglucose F18